NASDAQ: RFAIRf Acquisition Corp II Stock
$11.01+0.00 (+0%)
Updated Jun 3, 2026
RFAI Price
$11.01
Fair Value Price
N/A
Market Cap
$38.67M
52 Week Low
$10.52
52 Week High
$11.44
P/E
61.17x
P/B
-7.81x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.44M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.05
Operating Cash Flow
-$683k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RFAI Overview
RF Acquisition Corp II currently maintains no substantial operational activities. Its core objective is to execute a strategic business combination, which may include a merger, share or asset acquisition, or corporate reorganization, with other enterprises. The company intends to focus its search for potential partners within the technology sector in Asia, specifically seeking out businesses specializing in artificial intelligence, quantum computing, and biotechnology. Founded in 2024, its principal location is Singapore.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RFAI's potential to beat the market
- RFAI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
RFAI
RankedUnranked of 35
RankedUnranked of 35
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.78 | C | |
| $22.85 | C | |
| $11.20 | C |
Be the first to know about important RFAI news, forecast changes, insider trades & much more!
RFAI News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RFAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RFAI was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RFAI is poor value based on its earnings relative to its share price (61.17x), compared to the US market average (14.77x)
P/E vs Market Valuation
RFAI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RFAI due diligence checks available for Premium users.
Valuation
RFAI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
61.17x
Industry
15.68x
Market
14.77x
RFAI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RFAI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
RFAI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.81x
Industry
76.27x
RFAI's financial health
Profit margin
Revenue
$0.0
Net Income
$93.7k
Profit Margin
0%
RFAI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$53.1M
Liabilities
$5.2M
Debt to equity
-1.05
RFAI's short-term liabilities ($1.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RFAI's long-term liabilities ($4.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RFAI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RFAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$267.6k
Investing
-$180.0k
Financing
$145.0k
RFAI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
RFAI vs Shell Company Stocks
Rf Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.